The invention relates to an oligonucleotide derivative which comprises at
least one nucleoside building block of the formula (I) 1
The invention furthermore relates to nucleoside building blocks,
intermediates and processes for preparing the oligonucleotide derivatives
and the nucleoside building blocks. The invention also relates to
pharmaceutical compositions and to uses of the oligonucleotide
derivatives and the nucleoside building blocks.
